Coreg (carvedilol) for heart attack patients who have decreased heart function

Glaxo is now promoting Coreg (carvedilol) for heart attack patients who have decreased heart function.

Coreg is the first beta-blocker APPROVED for reducing the risk of death in these patients.

Some reps will say it's better than the "old" beta-blockers... metoprolol, atenolol, propranolol, etc.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote